Tafinlar - NDC Database

7 records found

Page:1

0078-0681 Apr 01, 2016
Tafinlar 75 mg Oral Capsule by Novartis Pharmaceuticals Corporation

0078-0682 Apr 12, 2016
Tafinlar 50 mg Oral Capsule by Novartis Pharmaceuticals Corporation

0078-1154 Mar 16, 2023
Tafinlar 10 mg Oral Tablet, for Suspension by Novartis Pharmaceuticals Corporation

0173-0846 Jun 10, 2013
Tafinlar 50 mg Oral Capsule by Glaxosmithkline LLC

0173-0847 Jun 10, 2013
Tafinlar 75 mg Oral Capsule by Glaxosmithkline LLC

53873-023 Dec 11, 2017
Dabrafenib Mesylate by Glaxosmithkline Inc

53873-024 Dec 11, 2017
Dabrafenib Mesylate by Glaxosmithkline Inc

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.